Main > ONCOLOGY (**) > VHL RCC > TREAT.: > USA. M. HIF-2α Inhibitor Table

---

USA. M. HIF-2α Inhibitor Table's subsections
(*) USA Approval Date: 2021. 08.13
Company
Generic Name: belzutifan
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 3
Patent>UpDate: 2021. 08.17.
PR Web-Site

USA. M. HIF-2α Inhibitor Table's products
This section has no products